中国现代药物应用
中國現代藥物應用
중국현대약물응용
CHINESE JOURNAL OF MODERN DRUG APPLICATION
2015年
12期
13-14
,共2页
降钙素原%超敏C反应蛋白%早期%新生儿感染
降鈣素原%超敏C反應蛋白%早期%新生兒感染
강개소원%초민C반응단백%조기%신생인감염
Procalcitonin%High-sensitivity C-reactive protein%Early%Neonatal infection
目的:分析降钙素原及超敏C反应蛋白检测在早期新生儿感染中的临床意义。方法80例细菌性感染新生儿依据病情程度分为重症感染组(40例)与局部感染组(40例);另选取同期的40例非感染新生儿作为对照组。对三组新生儿均进行降钙素原及超敏C反应蛋白检测,对比检测结果。结果重症感染组的降钙素原及超敏C反应蛋白水平分别为(13.38±3.52)ng/L、(25.73±4.68)mg/L,明显高于局部感染组及对照组(P<0.05);且局部感染组明显高于对照组(P<0.05)。结论降钙素原及超敏C反应蛋白检测能够较准确的判断早期新生儿感染,具有非常重要的临床意义。
目的:分析降鈣素原及超敏C反應蛋白檢測在早期新生兒感染中的臨床意義。方法80例細菌性感染新生兒依據病情程度分為重癥感染組(40例)與跼部感染組(40例);另選取同期的40例非感染新生兒作為對照組。對三組新生兒均進行降鈣素原及超敏C反應蛋白檢測,對比檢測結果。結果重癥感染組的降鈣素原及超敏C反應蛋白水平分彆為(13.38±3.52)ng/L、(25.73±4.68)mg/L,明顯高于跼部感染組及對照組(P<0.05);且跼部感染組明顯高于對照組(P<0.05)。結論降鈣素原及超敏C反應蛋白檢測能夠較準確的判斷早期新生兒感染,具有非常重要的臨床意義。
목적:분석강개소원급초민C반응단백검측재조기신생인감염중적림상의의。방법80례세균성감염신생인의거병정정도분위중증감염조(40례)여국부감염조(40례);령선취동기적40례비감염신생인작위대조조。대삼조신생인균진행강개소원급초민C반응단백검측,대비검측결과。결과중증감염조적강개소원급초민C반응단백수평분별위(13.38±3.52)ng/L、(25.73±4.68)mg/L,명현고우국부감염조급대조조(P<0.05);차국부감염조명현고우대조조(P<0.05)。결론강개소원급초민C반응단백검측능구교준학적판단조기신생인감염,구유비상중요적림상의의。
ObjectiveTo analyze the clinical significance of procalcitonin and high-sensitivity C-reactive protein detection in early neonatal infection.MethodsA total of 80 neonates with bacterial infection were divided by their severity into severe infection group (40 cases) and local infection group (40 cases). Another 40 neonates without infection were taken as control group. Procalcitonin and high-sensitivity C-reactive protein were detected in the three groups, and detection results were compared.ResultsThe severe infection group had procalcitonin and high-sensitivity C-reactive protein levels as (13.38±3.52) ng/L and (25.73±4.68) mg/L, which were all obviously higher than the local infection group and control group (P<0.05); and those in local infection group were also higher than the control group (P<0.05).ConclusionProcalcitonin and high-sensitivity C-reactive protein detection can accurately make judgment for early neonatal infection, and it contains important clinical significance.